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Abstract
Dopaminergic neurons in the ventral tegmental area, the major midbrain nucleus projecting
to the motor cortex, play a key role in motor skill learning and motor cortex synaptic plastici-
ty. Dopamine D1 and D2 receptor antagonists exert parallel effects in the motor system:
they impair motor skill learning and reduce long-term potentiation. Traditionally, D1 and D2
receptor modulate adenylyl cyclase activity and cyclic adenosine monophosphate accumu-
lation in opposite directions via different G-proteins and bidirectionally modulate protein ki-
nase A (PKA), leading to distinct physiological and behavioral effects. Here we show that
D1 and D2 receptor activity influences motor skill acquisition and long term synaptic potenti-
ation via phospholipase C (PLC) activation in rat primary motor cortex. Learning a new
forelimb reaching task is severely impaired in the presence of PLC, but not PKA-inhibitor.
Similarly, long term potentiation in motor cortex, a mechanism involved in motor skill learn-
ing, is reduced when PLC is inhibited but remains unaffected by the PKA inhibitor. Skill
learning deficits and reduced synaptic plasticity caused by dopamine antagonists are pre-
vented by co-administration of a PLC agonist. These results provide evidence for a role of
intracellular PLC signaling in motor skill learning and associated cortical synaptic plasticity,
challenging the traditional view of bidirectional modulation of PKA by D1 and D2 receptors.
These findings reveal a novel and important action of dopamine in motor cortex that might
be a future target for selective therapeutic interventions to support learning and recovery of
movement resulting from injury and disease.
Introduction
Dopaminergic neurotransmission is involved in a large variety of physiological functions in-
cluding voluntary motor activity, reward control, learning and cognition[1,2,3]. Dysfunction of
the dopaminergic system has been linked to pathologies such as schizophrenia, drug addiction
and Parkinson’s disease[3]. Dopamine (DA) modulates glutamatergic and GABAergic
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neurotransmission via D1-like and D2-like receptor subclasses to exert opposing physiological
effects. In the prefrontal cortex (PFC) DAmodulates pyramidal cell excitability directly and in-
directly through its actions on local GABAergic interneurons[4]. D1 stimulation increases in-
terneuron excitability leading to increased evoked and spontaneous inhibitory postsynaptic
currents (IPSCs) in pyramidal neurons, while D2 stimulation reduces IPSCs[5,6]. Typically,
D1-like receptors (D1, D5) activate adenylyl cyclase, whereas DA D2-like receptors (D2, D3,
D4) inhibit adenylyl cyclase[7]. In the striatum, D1 receptors are positively coupled to adenylyl
cyclase-PKA resulting in enhanced excitability in striatonigral medium spiny neurons (MSNs),
whereas D2 receptor signaling exerts the opposite effect in striatopallidal MSNs[7]. DA recep-
tor activation also plays a critical role in modulating synaptic strength of glutamatergic inputs
[8,9]. D1 receptors are required for the induction of LTP at glutamatergic synapses in direct
pathway MSNs[8,9], and at hippocampal synapses[10,11]. Activation of D2 receptors on stria-
tal MSNs of the indirect pathway is necessary for long-term depression (LTD)[8,9]. DA recep-
tors also have the ability to form heterooligomers which form the starting point of a different
signaling pathway[12]. The D1-D2 heteromer has been reported to be coupled to Gq/11 to acti-
vate PLC which triggers intracellular Ca2+ release, and phosphorylation of calcalcium/calmod-
ulin-dependent protein kinase II (CaMKII)[13], which is known to play a key role in both
long-term potentiation (LTP) and LTD of synaptic transmission[14].
In Parkinson’s disease (PD), degeneration of the DA neurons projecting to the neocortex
leads to a 70% reduction of DA fibers within the primary motor cortex (M1) and other frontal
cortical areas[1]. Successful motor skill learning and synaptic plasticity in M1 requires intact
dopaminergic signaling within M1[15]. Dopaminergic projections to M1 originate predomi-
nantly in the midbrain‘s ventral tegmental area (VTA)[16]. Destruction of dopaminergic neu-
rons in the VTA by 6-hydroxydopamine (6-OHDA) depletes dopaminergic terminals in M1
and impairs motor skill acquisition[15,16]. Additionally, LTP in M1, a mechanism involved in
skill acquisition[17,18] is reduced by both D1 and D2 receptor antagonists[15]. The parallel ef-
fects of antagonists cannot be explained by the traditional mechanism of opposing D1 and D2
receptor monomer effects on the cAMP-PKA pathway. Here we tested the hypothesis that DA
influences M1 synaptic plasticity and motor skill acquisition via activation of the intracellular
PLC signaling pathway. We show that inhibition of PLC but not of PKA prevents the acquisi-
tion of a reaching skill and impairs LTP in M1. PLC agonist treatment abrogates the learning
deficit and LTP impairment induced by DA antagonists in M1.
Material and Methods
Animals
All experiments were performed with adult male Long-Evans rats (8–10 weeks, 250–350 g)
housed in pairs on a 12/12-hr light/dark cycle. Experiments and procedures were conducted
according to the German and Swiss national guidelines and approved by the Animal Care
Committee of the State of Baden Württemberg (Germany) or the Committee for Animal Ex-
perimentation of the Kanton of Zürich (Switzerland). Most chemicals were purchased from
Tocris bioscience (Bristol, UK): H-89 hydrochloride (PKA inhibitor), U-73122 (active) and U-
73343 (inactive) (PLC inhibitor), m-3m3fbs (PLC agonist), SCH23390 hydrochloride (D1 an-
tagonist), bicuculline methiodide (GABAA antagonist, used for LTP induction). Raclopride
tartrate salt (D2 antagonist) was purchased from Sigma-Aldrich Chemie GmbH (Steinheim,
Germany).
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Motor skill training
Training sessions were performed at the beginning of the dark phase. Animals were food-re-
stricted for 24 hr prior to the first pre-training session. During training animals were kept
slightly over their initial weight (336.7 ± 31.2 g) by providing 50 mg/kg of standard lab diet
after each training session. Water was given ad libitum. For all experiments, litter-mates were
equally assigned to experimental groups.
The single pellet reaching task was performed as previously described [20]. The training
cage had a vertical window with a sliding door in the front wall and a light sensor in the rear
wall. Nose-poking the sensor opened the sliding door giving access to single food pellets
(45 mg, Bio-serve, Frenchtown, NJ, USA). During the 5 day shaping period rats retrieved pel-
lets with their tongue from a small horizontal board 0.5 cm distance from the window. After
shaping, single food pellets were placed on a post with a slightly larger diameter than the pellets
in 1.5 cm distance from the window. Thus, pellets were accessible only with the forelimb. The
first training session consisted of 50 door openings (= trials) and was used to determine fore-
limb preference which was necessary for implantation of cannulas and needles in the contralat-
eral hemisphere. For all subsequent training sessions which consisted of 100 trials the post was
shifted to one side of the window to facilitate reaching. To retrieve the pellet rats had to extend
the forelimb towards the pellet, grasp, retrieve and bring the pellet to the mouth[19]. Each
reaching trial was scored as “successful” or “unsuccessful”. The success rate was defined as the
ratio of the number of successful trials and the total number of trials per session, i.e. 100. The
latency between pellet removal and subsequent door opening was used as an index of motiva-
tion [20].
Surgical Procedures
All surgical procedures were performed under ketamine (70 mg/kg, i.p.) and xylazine anesthe-
sia (5 mg/kg, i.p.) with the rats fixed in a stereotactic frame (Stoelting Co., Wood Dale, IL,
USA). Additional ketamine doses were administered as needed. Body temperature was moni-
tored using a heating pad. Buprenorphin (0.01 mg/kg, i.p.) was given after surgery for pain re-
lief. All permanent implants were anchored onto the skull with two screws (2 mm diameter)
placed in the frontal and occipital skull. Screws and guide cannulas were connected and stabi-
lized using bone cement (FlowLine, Heraus Kulzer, Dormagen, Germany).
Cannula implantation. For acute drug injections into M1, PLC- and PKA inhibitors, DA
antagonists and PLC agonist, were administered via guide cannula systems (15 mm long, Uni-
med SA, Lausanne, Switzerland) implanted into the center of the M1 forelimb representation
(3 mm lateral, 1 mm anterior to bregma, 900 μm below dura). Prior to implantation forelimb
preference for reaching was determined (see above) and cannulas were implanted into the con-
tralateral hemisphere. After 3 days of recovery, rats were trained for 7 successive days. Drugs
were injected 30 min before the training session on days 2 and 3 (34 Gauge needle, Hamilton
Bonaduz AG, Switzerland). A volume of 0.5 μl was injected over 90 sec using a microsyringe
(5 μl, Hamilton Bonaduz AG, Switzerland) connected via plastic tubing (10 cm, PE40 Plastics
One, Roanoke, VA USA) to a microinjection pump (Nano-injector, Stoelting Co., Wood Dale,
IL, USA). Following the last training session cannulas were removed and location was
verified histologically.
Osmotic minipump implantation. For continuous drug application into M1, PLC- and
PKA inhibitors, and vehicle were administered via osmotic minipumps (0.25 μl/hr, 100 μl vol-
ume, model 1002, Alzet, Cupertino, CA, USA). Prior to minipump implantation the forelimb
preference was determined and the injection needle was implanted into the M1 forelimb area
of the contralateral hemisphere. Minipump reservoirs were implanted subcutaneously in the
MI Dopamine Activates PLC Pathway
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neck area and connected to the implanted needle via plastic tubing. The pump was loaded with
either PLC or PKA inhibitors followed by a vehicle solution. Double-loading ensured that vehi-
cle was released during the recovery period from surgery and inhibitors only during the train-
ing period. After the last training session minipumps were explanted and their location
verified histologically.
Histological verification. The positioning of cannulas and needles for minipumps was
verified histologically using Nissl staining. No animal had to be excluded because of cannula or
needle misplacement.
Drug applications
For cannula injections, PKA inhibitor (H89), PLC agonist (m-3m3fbs) and DA antagonists
(SCH23390 and raclopride) were dissolved in 0.9% saline, active and inactive PLC inhibitor
(U73122 and U73343) in DMSO at 100 μM, and injected in volumes of 0.5 μl. For minipump
injections, PLC- and PKA inhibitor were continuously administered at 100 μM concentration
for the entire training period (0.25 μl/hr, 100 μl volume). For electrophysiological recordings,
the PLC agonist (25 μM) and the PLC inhibitor (10 μM) were dissolved in DMSO (0.005%).
The PKA inhibitor (20 μM), the D1 and the D2 antagonists (5 μM) were dissolved in saline.
Drugs were added to the solution superfusing the slice.
In vitro slice preparation
Deeply anesthetized rats (pentobarbital, 50 mg/kg) were decapitated, their brains quickly re-
moved and immersed in cold (5–7°C), oxygenated (95% O2/5% CO2) artificial cerebrospinal
fluid (ACSF) containing (in mM): 126 NaCl, 3 KCl, 1.25 NaH2PO4, 1 MgSO4, 2 CaCl2, 26
NaHCO3, 10 dextrose. Coronal slices (500 μm) including the M1 forelimb area (1.5–3.5 mm
anterior to Bregma, 2–4 mm lateral) of both hemispheres were prepared using a vibratome.
Slices were transferred to a temperature controlled (34 ± 0.5°C) interface chamber and super-
fused with oxygenated ACSF at a rate of 1–2 ml/min. Slices were allowed to recover for at least
one hour prior to the start of recordings.
Stimulation and recording
To record intracortical horizontal connections in brain slices, concentric bipolar stimulation
electrodes (FHC, Main St Bowdoin, USA) were positioned mirror symmetrically in layer II/III
of each hemisphere 2–2.5 mm lateral to the midline. Recording electrodes were placed 500 μm
lateral to the stimulation electrodes. Extracellular field potentials (FP) were evoked by 0.2 ms
pulses at 0.03 Hz and recorded simultaneously in both hemispheres. Stimulation intensity was
adjusted until a response of 0.2 mV was recorded, which was defined as the threshold intensity.
Synaptic strength was determined by generating input-output relationships at multiples of
threshold intensity.
LTP induction
The stimulus intensity eliciting 50% of the maximum peak amplitude was used for all measure-
ments before and after LTP induction. Baseline amplitudes were recorded using single stimuli
applied every 30 sec. Following a 30-min stable baseline period, LTP was induced by theta
burst stimulation (TBS), consisting of 10 trains at 5 Hz, each train composed of 4 (200 μsec)
pulses at 100 Hz, repeated 5 times every 10 sec. During TBS the stimulation intensity was dou-
bled. TBS was applied immediately after transient, local application of the GABAA receptor
MI Dopamine Activates PLC Pathway
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antagonist bicuculline methiodide (3.5 mM) at the field potential recording site until response
amplitude increased to 150–200% of baseline.
Statistical Analysis
Repeated measures analysis of variance was used to explore the effects of drug injections on
reaching success rate or intertrial latencies (using Graphpad Prism version 6, Graphpad Inc,
USA). The within-subjects variable training day, the between-subjects variable group and their
interaction were included as independent predictors. If group or the interaction group x train-
ing day were significant, post hoc tests were performed using Dunett’s test for comparison with
the control group. Two-tailed probability less or equal to 5% was considered significant.
Results
PLC inhibitor impairs motor skill acquisition and M1 synaptic plasticity
To establish whether DA activates intracellular PKA and/or PLC signaling pathways in M1
specific inhibitors were continuously infused directly into the M1 forelimb area of adult rats
via osmotic minipumps while the animals were learning a new motor skill (Fig 1A). Rats were
trained to reach with a single forepaw through a small aperture to reach and grasp single food
Fig 1. Experimental design. (a) Timeline for experiments shown in Fig 2A using continuous drug release via minipump (red bar) during motor skill training.
(b) Timeline for experiments shown in Fig 2B, Fig 3A and 3B using acute drug injections on day 2 and 3 of motor skill training (red arrows). (c) Timeline for
experiments shown in Fig 2 using continuous drug release via minipump (red bar) after successful acquisition of the motor task.
doi:10.1371/journal.pone.0124986.g001
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pellets for 8 successive days. Learning curves as illustrated in Fig 2 indicate a significant im-
pairment of skill acquisition in animals that received intracortical infusion of the PLC inhibitor
U73122 while infusion of PKA inhibitor H89 had no effect (N = 6 per inhibitor, N = 12 con-
trols; interaction of group by time: F (16, 168) = 2.557, p = 0.0015, significant post-hoc Dun-
netts‘s tests for comparison between PLC inhibitor and control for training session 5: mean
difference -14.26 (CI -26.55 to -1.977); session 6: -19.30 (CI -31.59 to -7.016); session 7: -13.35
(CI -25.64 to -1.067); and session 9:, -13.43 (CI -25.71 to -1.141); Fig 2A left). Time intervals
between reaching trials were used as a measure of motivation. They were significantly longer in
all training sessions in PLC inhibitor-treated rats as compared with vehicle-treated controls
but were unaffected in PKA inhibitor-treated rats (main effect of group: F (2, 20) = 7.398,
p = 0.0039, significant post-hoc Dunnett‘s tests for comparison between PLC inhibitor and
control: session 3: mean difference 7.910 (CI 2.891 to 12.93); session 4: 5.970 (CI 0.9507 to
10.99); and session 6: 6.978 (CI 1.959 to 12.00); Fig 2A right). Similar results were achieved
when the drugs were applied via implanted cannulas during the steepest part of the learning
curve, on day 2 and 3 of skill training (30 minutes prior to training; Fig 1B). Skill acquisition
was impaired in the presence of PLC- but not PKA inhibitor compared to control rats (Fig 2B).
This data set revealed a significant interaction of group and time (F (12, 150) = 1.980,
p = 0.0297), but post hoc tests comparing the groups individually to control were not signifi-
cant (p>0.8). There were no differences between groups with respect to the time intervals be-
tween reaching trials. The inset in Fig 2B emphasizes the lack of success improvement between
days 2 and 3.
Previous studies have shown that motor skill acquisition is accompanied with increases in
synaptic strength[17], and LTP occlusion[18], in M1 horizontal connections. Because motor
skill learning requires intracellular PLC signaling we tested the hypothesis that PLC activation
is also necessary for learning-induced synaptic strengthening. This was accomplished by re-
cording maximum synaptic strength (LTP saturation) in layer II/III horizontal connections in
the M1 forelimb area of brain slices in control and in the presence of PLC and PKA inhibitors.
LTP was induced by multiple attempts of theta burst stimulation preceded by local transient
application of bicuculline. Results show that LTP saturation was significantly reduced when
PLC was blocked with U-73122 (117.2±4.8%, N = 8), as compared to the control condition
(160.1±8.34%, N = 7, p = 0.0012, Fig 2C). Superfusion of slices with the PKA inhibitor H-89 re-
sulted in LTP that was not significantly different from control LTP (148.5%±5.1%, N = 5,
p = 0.31, Fig 2D), but significantly different from LTP in the presence of the PLC inhibitor
(p = 0.0027). These results suggest that PLC but not PKA signaling is required for motor skill
acquisition and synaptic plasticity. LTP results are summarized in Fig 2E.
PLC inhibitor has no effect on movement execution and M1 synaptic
transmission
To determine whether PLC signaling is also involved in movement execution, rats received
continuous infusion of PLC inhibitor U-73122 into the M1 forelimb area after having acquired
the task successfully and learning curves had reached the asymptotic phase (Fig 1C). Reaching
performance was not affected when PLC was blocked (N = 5, t-test comparing the means of
sessions 6–8 and sessions 9–13, t(4) = 0.2820, p = 0.79, Fig 3A left). Likewise, the intertrial la-
tencies remained unaffected (t(4) = 1.907, p = 0.13, Fig 3A right), suggesting that PLC signaling
is only necessary for skill learning but not for movement execution after a skill had been
acquired successfully.
We examined whether blocking PLC and PKA affects baseline synaptic transmission by
measuring evoked responses of layer II/III horizontal connections in the M1 forelimb area.
MI Dopamine Activates PLC Pathway
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Extracellular field potentials (FP) recorded before and after superfusion with the PLC inhibitor
(Fig 3B) or the PKA inhibitor remained unchanged in shape and amplitude (for PLC
Fig 2. PLC inhibitor impairs motor skill acquisition and the potential for M1 synaptic plasticity. (a) Motor skill acquisition was assessed in rats that
received continuous intracortical injection (grey bar) of PLC inhibitor U-73122 (blue), PKA inhibitor H-89 (green) and inactive PLC inhibitor U-73343 (black)
into the M1 forelimb area via osmotic minipumps. The success rate and the latency, a measure of motivation, were impaired in the presence of PLC but not
PKA inhibitor. Error bars indicate SEM. (b) Temporary application of PLC and PKA inhibitors directly to M1 on training day 2 & 3 (time of steepest learning)
reveal the same effect as with continuous application. Arrows indicate local injection days. The inset illustrates the rate of learning from day 1–2, day 3–4, and
day 4–5 indicating a lack of improvement from day 2–3. (c) Maximum synaptic strength (LTP saturation) by repeated induction of LTP (multiple arrows) in
layer II/III horizontal connections in brain slices. Peak amplitudes were assessed in the M1 forelimb area in ACSF (dark blue) and in the presence of PLC
inhibitor U-73122 (light blue). Each FP trace (insets) represents an average of 10 individual responses at times indicated by numbers. (d) Maximum LTP in
the presence of PKA inhibitor is not significantly different from control LTP. Arrows indicate multipe LTP attempts. (e) Summary histogram of LTP. Grey:
Control; green: PKA inhibition; blue: PLC inhibition.
doi:10.1371/journal.pone.0124986.g002
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experiments: baseline 0.788±0.050 mV, N = 9; PLC inhibitor 0,784±0.052 mV, N = 9, p =
0.48; for PKA experiments: baseline 1.15±0.048 mV, PKA inhibitor 1.16±0.049 mV, N = 5,
p = 0.61). Thus, blocking intracellular PLC signaling pathway affects only synaptic plasticity
but not baseline synaptic transmission.
PLC activation prevents DA antagonist-induced learning deficit and LTP
Previous findings showed that D1 and D2 receptor antagonists significantly impair motor skill
acquisition and synaptic plasticity[15]. Similarly blocking the PLC pathway drastically reduces
the capacity for skill learning and synaptic plasticity (Fig 2). As DA binding to D1 and D2 re-
ceptors can activate the PLC signaling pathway[21], we examined whether PLC activation in
the presence of D1 or D2 receptor antagonists could prevent the observed learning impairment
and LTP deficits. The PLC agonist m-3m3fbs was co-administered with either D1 receptor an-
tagonist SCH23390 or D2 receptor antagonist raclopride on day 2 and 3 during motor skill
training (Fig 1B). DA receptor antagonists alone significantly impaired skill learning compared
to control while learning deficits were prevented by co-administration of the PLC agonist m-
3m3fbs (D1 antagonist SCH23390 N = 9, SCH23390+m-3m3fbs N = 7, control N = 7, group
by time interaction: F (14, 140) = 1.974, p = 0.0238, significant post-hoc Dunnett’s test
between SCH 23390 and control for training session 3: mean difference -12.13 (CI -23.41 to
-0.8420); and 4: -12.57 (CI -23.86 to -1.290); Fig 4A left; D2 antagonist raclopride N = 10,
Fig 3. PLC activation is not necessary for the execution of an already acquired task and does not
affect baseline synaptic transmission. (a) Continuous intracortical infusion of PLC inhibitor (grey bar) for 5
days following successful acquisition of the skilled reaching task did not affect success rate or intertrial
latency. Insets illustrate mean±SEM before (day 6–8) and following (day 9–13) treatment with PLC inhibitor
indication a lack of change. Error bars indicate SEM. (b) Amplitudes and shapes of extracellular field
potentials (FP) in layer II/III horizontal connections of the M1 forelimb area remained unchanged in the
presence of PLC inhibitor. Traces are examples of extracellular FPs at baseline stimulation intensity before
(control, dark blue) and after inhibitor application (light blue).
doi:10.1371/journal.pone.0124986.g003
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raclopride+m-3m3fbs N = 6, control N = 6, m-3m3fbs alone N = 6, group by time interaction:
F (21, 168) = 2.645, p = 0.0003, significant post-hoc Dunnett’s test between raclopride and con-
trol for training session 3:, mean difference -17.00 (CI -30.71 to -3.286), Fig 4B left). All Dun-
nett’s test for comparisons between DA-antagonist+PLC-agonist groups and control were not
significant. To exclude possible additive but mechanistically unrelated effects of DA antago-
nists and the PLC agonist, one group of rats was treated with PLC agonist alone. The learning
curves of PLC agonist treated rats and vehicle treated controls were not significantly different
(post-hoc Dunnett’s tests were not significant). Intertrial latencies in rats treated with DA-re-
ceptor antagonists, PLC agonist, and PLC agonist combined with DA antagonists were not sig-
nificantly different from vehicle-treated controls (SCH23390 experiment group by time effect:
F (14, 140) = 1.157, p = 0.34, raclopride experiment: F (21, 161) = 1.090, p = 0.36, Fig 4A and
4B right). These results are consistent with the hypothesis that DA binding to D1 and D2 stim-
ulates the PLC signaling pathway.
We further examined whether activation of the PLC signaling pathway can rescue DA antag-
onist-induced LTP impairment. Synaptic strength and plasticity were determined in M1 intra-
cortical connections before and after co-application of D1 or D2 receptor antagonist together
with the PLC agonist. Saturating LTP by multiple attempts of TBS in the presence of either D1
antagonist SCH23390 plus PLC agonist m-3m3fbs or D2 antagonist raclopride plus m-3m3fbs
resulted in levels of LTP (154.4±12.8, N = 4 and 162.9±9.82%, N = 11 respectively; Fig 5A left)
comparable to controls (160.1±8.34%, N = 7, P = 0.35 and p = 0.85 respectively; Fig 2C), and
Fig 4. PLC activation prevents DA antagonist-induced learning deficits. (a) Co-administration of the PLC agonist m-3M3FBS and D1 receptor
antagonist SCH 23390 (red) prevents SCH 23390 (orange) induced deficit in the success rate (left) compared to vehicle injected control (black). Intertrial
latencies remained unaffected regardless of drug or drug combination injected (right). (b) D2 receptor antagonist raclopride (yellow) impaired skill acquisition.
This impairment was prevented by PLC agonist co-administration (red). PLC agonist alone (green) had no effect on learning as compared to controls (black).
Intertrial latencies remain unaffected by all treatments (right). Error bars indicate SEM. Arrows indicate days of local injections.
doi:10.1371/journal.pone.0124986.g004
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the m-3m3fbs alone (150.3±9.81%, N = 5, p = 0.42 and p = 0.68 respectively). Thus, activation of
the PLC pathway rescues LTP impairment resulting from D1 or D2 receptor blockade. The his-
togram (Fig 5A right) emphasizes a major role of DA induced intracellular PLC activation in M1
synaptic plasticity. Baseline synaptic transmission was not affected by D1 antagonist SCH23390,
D2 antagonist raclopride and PLC agonist m-3m3fbs alone [15], or m-3m3fbs co-administered
with either SCH23390 or raclopride (Fig 5B left). The extracellular FPs remained unchanged in
shape and amplitude. The histogram in Fig 5B (right) illustrates drug effects as relative change to
control condition (before drug application) (PLC agonist: 1.03±0.113, N = 7, P = 0.85; PLC an-
tagonist: 1.01±0.07, N = 9, P = 0.96; D2 antagonist: 0.995±0.061, N = 10, P = 0.95; D1 antagonist
& PLC agonist: 0.99±0.11, N = 4, P = 0.60: D2 antagonist & PLC agonist: 1.01±0.065, N = 13,
P = 0.96).
Fig 5. Activation of intracellular PLC pathway rescues the LTP impairment caused by DA receptor block. (a) Maximum synaptic strength of horizontal
layer II/III connections, measured by saturating LTP with multiple attempts of TBS (arrows) in raclopride (D2antag) co-administered with m-3m3fbs
(PLCactivator, red) resulted in normal amounts of LTP (left). m-3m3fbs alone did not affect LTP saturation (green). The histogram (right) illustrates LTP
saturation for control condition (grey), PLC agonist (green), PLC antagonist (blue), D2 antagonist (yellow). D1 and D2 antagonist co-applied with the PLC
agonist (red) illustrates the rescue of D1 and D2 block. (b) FP amplitudes were not affected by co-administration of D2 antagonist and PLC agonist or by PLC
agonist alone (left). The histogram (right) illustrates group data of synaptic strength for all the different conditions (color code as in a). Values are calculated
relative to the baseline recordings before drug application.
doi:10.1371/journal.pone.0124986.g005
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Discussion
Dopaminergic neurons in the VTA, the major midbrain nucleus projecting to M1, play a key
role in motor skill learning [16]. Our previous study showed that D1 and D2 receptor antago-
nists in M1 both impair motor skill learning and LTP formation [15]. To gain insight into the
cellular mechanisms underlying the seemingly parallel effects of D1 and D2 receptor antago-
nists on LTP, we examined the intracellular pathways, specifically PKA and PLC signaling in
M1 using specific inhibitors infused directly into the M1 forelimb area. The results support the
hypothesis that dopaminergic signaling in M1 activates the intracellular PLC pathway to enable
optimal motor skill learning and M1 synaptic plasticity. We found that PLC inhibition with in-
tact DA transmission prevents skill learning and M1 LTP, while PLC activation in the presence
of D1 or D2 antagonists mitigates learning deficits and LTP impairment.
The intracellular cascades activated by DA receptor stimulation are complex and vary be-
tween brain regions, cell types, and receptor localization [22,23,24]. While DA receptors are
traditionally known to modulate cAMP signaling pathways, studies with ostensibly selective
agonists or antagonists suggest that PLC can be activated by D1-like receptors [24,25,26,27].
Nevertheless DA mediated PLC stimulation remains controversial [23]. Studies in knockout
mice indicate that D1-like dopaminergic activation of phosphoinositide hydrolysis is indepen-
dent of D1a DA receptors [28], whereas D5 receptor knockout mice have lost the ability to pro-
duce inositol phosphate or diacylglycerol messengers after stimulation with D1-like receptor
agonists [26]. Therefore, emerging evidence indicates that PLC activity can be mediated
through stimulation of the D5 receptors [24,29]. Further, immunolabeling shows immunoreac-
tivity for D1a, D2, and D5 receptors in the pyramidal tract neurons in the motor cortex [30].
As the D1-family antagonist SCH23390 does not discriminate between D1 and D5 receptors,
we cannot rule out a role for D5 PLC activation in M1.
The results of this study demonstrate that blocking D2 receptors impaired skill acquisition
and reduced long-term potentiation (LTP) within M1, a form of synaptic plasticity critically in-
volved in skill learning. These results are in agreement with human studies showing that D2 re-
ceptor block abolishes neuroplasticity in the human motor cortex [35], and animal studies that
suggest D2-like receptors can reinforce LTP expression by suppressing the induction of depo-
tentiation [36]. The finding that PLC activity rescues LTP impairment resulting from D2 recep-
tor blockade raises the possibility that D2 receptor activity acts to enhance the PLC signaling
via a novel pathway. D2 receptor stimulation has been shown to mobilize Ca2+ stores via acti-
vation of a PLC pathway leading to calcineurin-dependent reduction of L-type Ca2+ currents
[37]. Furthermore, George and coworkers reported that PLC signaling can occur via activation
of a D1-D2 heterodimer [12,13,31,32,33]. While the selectivity of the D1-D2 heteromer-selec-
tive agonist (SKF83959) used in these studies has been challenged [23,34], studies using sub-
type selective ligands suggest that concurrent stimulation of D1 and D2 subtypes is coupled to
calcium signaling [34].
D1 and D2 synergism has been reported to be a requirement for a variety of motor behav-
iors but the mechanism for this interaction remained obscure. In the PFC, which also receives
DA innervation from the VTA, the induction of LTD and LTP of glutamatergic synapses is
modulated by DA. DA acts through both D1 and D2 receptors to lower the threshold for the
induction of this LTD [38]. Conversely, prestimulation of D1 and D2 receptors converts
NMDA receptor-independent LTD to LTP [39]. D1 and D2 receptor stimulation in the nucleus
accumbens is required LTD [42]. for the expression of locomotor activity [40,41], and reward-
mediated processes, and concurrent D1 and D2 receptor activation had a cooperative effect
[40,42]. Behavioral synergism between D1 and D2 receptors in the striatum promotes motor
stereotypy [43]. This well documented behavioral synergy between D1 and D2 receptors could
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result from the formation of heterooligomers. Although heteromer formation in M1 is specula-
tive and needs further elucidation it could open novel possibilities for selective pharmacological
modulation of the DA-PLC pathway.
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